Elevance Health Inc. (NYSE: ELV) stock closed at 498.77 per share at the end of the most recent trading day (a -0.24% change compared to the prior day closing price) with a volume of 1.24M shares and market capitalization of 113.90B. Is a component of S&P 500 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 98200 people. Elevance Health Inc. CEO is Gail Koziara Boudreaux.

The one-year performance of Elevance Health Inc. stock is 12.9%, while year-to-date (YTD) performance is -2.77%. ELV stock has a five-year performance of 120.15%. Its 52-week range is between 431.96 and 549.52, which gives ELV stock a 52-week price range ratio of 38.24%

Elevance Health Inc. currently has a PE ratio of 18.60, a price-to-book (PB) ratio of 3.16, a price-to-sale (PS) ratio of 0.96, a price to cashflow ratio of 10.00, a PEG ratio of 2.32, a ROA of 6.18%, a ROC of -% and a ROE of 17.32%. The company’s profit margin is 4.34%, its EBITDA margin is -%, and its revenue ttm is $116.67 Billion , which makes it $488.49 revenue per share.

Of the last four earnings reports from Elevance Health Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $5.21 for the next earnings report. Elevance Health Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Elevance Health Inc. is Strong Buy (1.29), with a target price of $568.44, which is +19.68% compared to the current price. The earnings rating for Elevance Health Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Elevance Health Inc. has a dividend yield of 1.09% with a dividend per share of $5.12 and a payout ratio of -%.

Elevance Health Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 22.46, ATR14 : 12.37, CCI20 : 121.61, Chaikin Money Flow : -0.10, MACD : -1.20, Money Flow Index : 60.70, ROC : 3.27, RSI : 54.30, STOCH (14,3) : 73.44, STOCH RSI : 0.81, UO : 52.18, Williams %R : -26.56), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Elevance Health Inc. in the last 12-months were: Charles Morgan Kendrick (Option Excercise at a value of $1 806 785), Charles Morgan Kendrick (Sold 6 328 shares of value $3 091 872 ), Peter Haytaian (Option Excercise at a value of $730 699), Peter Haytaian (Sold 53 109 shares of value $24 467 585 ), Ramiro G. Peru (Sold 990 shares of value $464 191 ), Robert L. Dixon (Sold 420 shares of value $208 799 ), Ronald W. Penczek (Option Excercise at a value of $2 343 598), Ronald W. Penczek (Sold 10 372 shares of value $4 752 922 )